Probiotic potential of Lactobacilli with antagonistic activity against pathogenic strains: An in vitro validation for the production of inhibitory substances

Biomed J. 2017 Oct;40(5):270-283. doi: 10.1016/j.bj.2017.06.008. Epub 2017 Nov 10.

Abstract

Background: Probiotics, live cells with different beneficiary characteristics, have been extensively studied and explored commercially in many different products in the world. Their benefits to human and animal health have proven in hundreds of scientific studies. Based on rich bibliographic material, Curd is the potential source of probiotic Lactobacilli.

Method: The aim of the present study was to observe Lactobacilli with probiotic potential activities from different curd samples for isolation, identification and characterization of Lactobacillus species.

Results: Among the samples, thirty lactic acid bacterial strains were isolated, sixteen (16/30) best Lactobacillus isolates were selected by preliminary screening as potential probiotic for acid and bile tolerance, further confirmed using 16s rRNA identification. All the selected Lactobacillus isolates were then characterized in vitro for their probiotic characteristics and antimicrobial activities against pathogens and aggregation studies. The results indicated that selected potential probiotic isolates (T2, T4 and T16) were screened and confirmed as Lactobacillus. The isolates produced positive tolerance to excited pH, NaCl and bile salts, also revealed noticeable antimicrobial activities against pathogens. All the Lactobacillus isolates were susceptible to clinical antibiotics used. Besides, T2 isolate was constituted to retain stronger auto and co-aggregation and cell surface hydrophobicity capacity.

Conclusion: Based on the drawn results, T2, T4 and T16 Lactobacillus isolates were recognised as ideal, potential in vitro antimicrobial probiotic isolates against pathogens and studies are needed further in-vivo assessment and human health benefits in their real-life situations.

Keywords: Antimicrobial activity; Bacteriocin; Curd; Lactic acid bacteria; Lactobacillus species.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Bile Acids and Salts / pharmacology
  • Culture Techniques / methods
  • Lactobacillus / drug effects*
  • Lactobacillus / ultrastructure
  • Probiotics / pharmacology*
  • RNA, Ribosomal, 16S / drug effects*
  • RNA, Ribosomal, 16S / metabolism

Substances

  • Anti-Bacterial Agents
  • Bile Acids and Salts
  • RNA, Ribosomal, 16S